NorthRock Partners LLC Takes Position in Axon Enterprise, Inc. (NASDAQ:AXON)

NorthRock Partners LLC bought a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 933 shares of the biotechnology company’s stock, valued at approximately $555,000.

Other hedge funds have also recently modified their holdings of the company. New Wave Wealth Advisors LLC bought a new position in shares of Axon Enterprise during the fourth quarter valued at approximately $40,000. Y.D. More Investments Ltd bought a new position in Axon Enterprise in the fourth quarter worth approximately $45,000. Stonebridge Financial Group LLC bought a new position in Axon Enterprise in the fourth quarter worth approximately $53,000. GPS Wealth Strategies Group LLC grew its stake in Axon Enterprise by 74.1% in the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock worth $56,000 after purchasing an additional 40 shares in the last quarter. Finally, Berbice Capital Management LLC bought a new position in Axon Enterprise in the fourth quarter worth approximately $59,000. Institutional investors own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on AXON shares. Barclays increased their price objective on Axon Enterprise from $726.00 to $735.00 and gave the stock an “overweight” rating in a research note on Friday, May 9th. Northcoast Research cut Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Needham & Company LLC increased their price objective on Axon Enterprise from $600.00 to $750.00 and gave the stock a “buy” rating in a research note on Thursday, May 8th. Craig Hallum cut Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday, March 10th. Finally, The Goldman Sachs Group upped their target price on Axon Enterprise from $730.00 to $830.00 and gave the stock a “buy” rating in a report on Wednesday. One research analyst has rated the stock with a sell rating, one has given a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $652.73.

Axon Enterprise Stock Performance

Shares of AXON opened at $733.18 on Friday. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $735.68. The stock has a fifty day moving average price of $584.61 and a 200-day moving average price of $593.44. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The firm has a market cap of $57.08 billion, a PE ratio of 189.45, a P/E/G ratio of 5.17 and a beta of 1.24.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, beating the consensus estimate of $1.34 by $0.07. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The firm had revenue of $603.63 million during the quarter, compared to analyst estimates of $585.67 million. During the same quarter in the prior year, the business posted $1.15 EPS. The business’s revenue for the quarter was up 31.3% compared to the same quarter last year. Equities research analysts predict that Axon Enterprise, Inc. will post 5.8 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Jeri Williams sold 307 shares of the stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. This represents a 15.87% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction on Monday, April 21st. The shares were sold at an average price of $540.99, for a total value of $5,409,900.00. Following the sale, the chief executive officer now owns 3,063,982 shares of the company’s stock, valued at approximately $1,657,583,622.18. This represents a 0.33% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 23,764 shares of company stock worth $14,856,635. Insiders own 4.40% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.